BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, August 6, 2026...
FRANKLIN LAKES, N.J. (July 9, 2026) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has been named among the top-performing U.S.-based companies by...
First-ever disease focused fellowship program supports specialized endovascular training for physicians across Europe By Jane Hart, VP of Clinical Affairs, BD Interventional – Peripheral...
How PPAEMA and DEA guidance support secure, accountable medication management for EMS When seconds matter, emergency medical services (EMS) professionals must be empowered to provide lifesaving...
In just one day, BD associates help non-profits solve real operational challenges, delivering everything from strategy and communications plans to AI-driven tools, frameworks and measurable outcomes.
Discover the new BD. We create medical technology, devices and laboratory equipment for scores of different needs across the healthcare continuum. But we serve all of them with one single and relentless human purpose: advancing the world of health. This is how we make a difference in human health across generations. This is our work and this is our passion.
The BD Innovation and Engagement Center in Eysins Switzerland offers visiting healthcare professionals a collaborative and immersive environment to grasp the full scope of BD solutions to healthcare challenges across the care continuum.
